Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
Masamichi Ishioka, Norio Yasui-Furukori, Norio Sugawara, Hanako Furukori, Shuhei Kudo, Kazuhiko Nakamura Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan Objective: The strong association between psychiatric patients who receive antipsychotics and...
Guardado en:
Autores principales: | Ishioka M, Yasui-Furukori N, Sugawara N, Furukori H, Kudo S, Nakamura K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f7adeda1cbe40bdab0959b13420797a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014) -
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2019) -
The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka M, et al.
Publicado: (2014) -
The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo S, et al.
Publicado: (2015) -
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015)